NCI Cancer Bulletin: A Trusted Source for Cancer Research NewsNCI Cancer Bulletin: A Trusted Source for Cancer Research News
March 2, 2004 • Volume 1 / Number 9 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe

NCI Cancer Bulletin Archive

Page Options

  • Print This Page
  • Print This Document
  • View Entire Document
  • Email This Document
  • View/Print PDF

The information and links on this page are no longer being updated and are provided for reference purposes only.

Featured Article

Telehealth Demonstration Launched to Improve Cancer Research and Care

On March 1, HHS Secretary Tommy Thompson and NCI Director Andrew von Eschenbach launched a state-of-the-art, broadcast-quality telemedicine system at the King Hussein Cancer Center (KHCC) in Amman, Jordan.

"For so many regions of the world, technology and telemedicine will mean the difference between life and death for many patients," Thompson said. "I applaud the continued collaboration among all the nations who are working together to make our world a healthier place for all of us."

The demonstration of the system in Amman involved a link to St. Luke's Hospital in Dublin, Ireland, for a consultation on a patient at KHCC. The system will promote collaboration between cancer specialists, facilitate professional education and training, and permit consultation in cancer research protocols and patient care throughout Jordan and the Middle East, at selected sites in the United States as well as in the Republic of Ireland and Northern Ireland. Other sites around the globe are being planned.  Read more  

Director's Update

RPG Funding Policies for FY 2004

There has been some confusion in the grantee community about our R01 policy and whether the cuts might represent a reduction of support from a grantee's current award level. I hope this message corrects any misunderstandings, and clarifies the rationale behind our decisions.

Although NCI funding remains at a historically high level, our operating budget in the current fiscal year (FY 2004) is slightly lower than that of last year as a result of cost-of-living adjustments, an increasing number of noncompeting grants, and assessments to support the NIH Roadmap Initiative and other centralized activities. To maintain the momentum of scientific discovery, we will continue to fund the maximum number of competing R01 research grants. The abrupt change in our rate of growth, however, has necessitated a modification in our funding policies. To secure the funds necessary to maintain the R01 payline at the 20th percentile, we will reduce the award amount of competing grants to a greater degree than has been the case over the past two years. This budget adjustment will enable us to support 75 more R01 grants than would have been possible if we maintained budget reductions at recent levels.  Read more  

This NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads a national effort to eliminate the suffering and death due to cancer. Through basic and clinical biomedical research and training, NCI conducts and supports research that will lead to a future in which we can prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.